Peroxisome proliferator-activated receptor-g agonist rosiglitazone reduces circulating platelet activaty in patients without diabetes mellitus who have coronary artery disease - Sidhu, JS; Cowan, D; Tooze, JA (Am Heart J, 2001)
et al